Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

Website

http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-13-001.html

Sponsor

United States Department of Health and Human Services (HHS)

Food and Drug Administration (FDA)

Sponsor ID: RFA-FD-13-001     (Re-issue of RFA-FD-11-001)

Amount

Upper  $1,600,000USD

Office of Orphan Products Development intends to commit $14.1 million in FY 2014 and FY2015. Of the estimated FY 2014 funding ($14.1 million), approximately $10 million will fund non-competing continuation awards, and…more »

Requirements

Academic Institution

Commercial

Government

New Faculty/New Investigator

Nonprofit

Ph.D./M.D./Other Professional

Small Business

Citizenship or Residency

Unrestricted

Activity location

Unrestricted

Abstract

The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the… more »

Eligibility

Eligible Organizations Higher Education Institutions - Public/State Controlled Institutions of Higher Education - Private Institutions of Higher Education The following types of Higher Education Institutions are always… more »

Keywords

• Pharmacotherapy
• Clinical Trial
• Orphan Rare Diseases

Upcoming Deadlines

Note

The expiration date is February 6, 2014 (October 16, 2014 for resubmission applications).

Date

What's Due

Notes

01 Nov 2013
Confirmed

Application
Sponsor deadline - required

Resubmissions are due.

 

05 Feb 2014
Confirmed

Application
Sponsor deadline - required

  

 

15 Oct 2014
Confirmed

Application
Sponsor deadline - required